Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Hank Payments Achieves Record Growth in its Profitable Auto Channel (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NetraMark Holdings Inc C.AIAI

Alternate Symbol(s):  AINMF

Healthcare Medical Devices
NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.


CSE:AIAI - Post by User

NetraMark Holdings Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(268)
•••
Post by stockpatrolon Nov 01, 2021 5:39pm
53 Views
Post# 34074980

Has anyone checked out $MEND.c / $MNNDF ?

Has anyone checked out $MEND.c / $MNNDF ?

Has anyone checked out $MEND.c / $MNNDF ? Nurosene health has created an app hoping to improve mental health by introducing healthy habits into your routine quickly and efficiently.

 

https://ca.finance.yahoo.com/quote/MEND.CN?p=MEND.CN&.tsrc=fin-srch 

 

Due to cost and stigmatization 75-85% don’t receive treatment for mental disorders. $MEND.c / $MNNDF hopes to challenge that by giving you what you need to ensure your mind and body have the necessary ingredients to thrive. 

 

https://twitter.com/nurosene

 

The mental health app market size is expected to $310Billion by 2027. Some apps like Calm (meditation / relaxation app) have been valued at $2B. I highly recommend you check out $MEND.c / $MNNDF with celebrity sponsor Micheal Phelps I think they are set up to be something big 

 

https://cdn.sanity.io/files/18g0k2jo/production/6447b0967d9b200435dc3e248f31fb51ab76b510.pdf 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities